GlassScriptPhysician profile
Steven A Yarows
NPI 1275532087
$4,205.70
in general payments reported to CMS, 2019-2025
6 companies · $1,315 in 2025
The $1,315 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $1,129 · 2021: $1,360 · 2025: $1,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,225 · Food and Beverage: $90.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,225.00 |
| Food and Beverage | $90.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hill-Rom Services, INC | $1,360.00 | 2021 | |
| Baxter Healthcare | $1,225.00 | 2025 | Hillrom - Welch Allyn Home Blood Pressure Monitor, Hillrom - Flexiport Disposable Blood Pressure Cuffs, Hillrom - Abpm 6100 Blood Pressure Monitor |
| Astrazeneca Pharmaceuticals LP | $1,219.04 | 2020-2025 | |
| Welch Allyn | $375.11 | 2019 | |
| Gilead Sciences, INC. | $26.55 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Yarows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.